Your browser doesn't support javascript.
loading
Premorbid angiotensin converting enzyme inhibitors or angiotensin II receptor blockers in patients with sepsis.
Hasegawa, Daisuke; Lee, Young Im; Prasitlumkum, Narut; Chopra, Lakshay; Nishida, Kazuki; Smith, Robert L; Sato, Ryota.
Affiliation
  • Hasegawa D; Department of Internal Medicine, Mount Sinai Beth Israel, NY, USA.
  • Lee YI; Department of Pulmonary and Critical Care Medicine, Mount Sinai Beth Israel, NY, USA.
  • Prasitlumkum N; Department of Cardiology, University of California Riverside School of Medicine, CA, USA.
  • Chopra L; Department of Internal Medicine, Mount Sinai Beth Israel, NY, USA.
  • Nishida K; Department of Biostatistics, Nagoya University Graduate School of Medicine, Aichi, Japan.
  • Smith RL; Department of Pulmonary and Critical Care Medicine, New York University Grossmann School of Medicine, NY, USA; Department of Pulmonary and Critical Care Medicine, Veterans Affairs, New York Healthcare System, NY, USA.
  • Sato R; Department of Critical Care Medicine, The Queen's Medical Center, HI, USA. Electronic address: st051035@gmail.com.
Am J Emerg Med ; 62: 69-77, 2022 12.
Article in En | MEDLINE | ID: mdl-36270096
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Sepsis / Angiotensin Receptor Antagonists Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Angiotensin-Converting Enzyme Inhibitors / Sepsis / Angiotensin Receptor Antagonists Type of study: Clinical_trials / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limits: Humans Language: En Year: 2022 Type: Article